| Name | ZED-1227 |
|---|
| Description | ZED-1227 is a specific and oral transglutaminase 2 (TG2) inhibitor, which can block inflammation-induced TG2 expression and activity. ZED-1227 is a promising agent for the treatment of celiac disease (CeD)[1]. |
|---|---|
| Related Catalog | |
| Target |
TG2[1] |
| References |
| Molecular Formula | C26H36N6O6 |
|---|---|
| Molecular Weight | 528.60 |